🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Blue Jet Healthcare Limited BLUEJET NIFTY_SMALLNSEPHARMA

Healthcare · Biotechnology · India
https://www.bluejethealthcare.com
Company Profile ↓
₹605.40
-33.88% 1Y
Mkt Cap₹10,501.60 Cr
P/E42.37
P/B7.73
Div. Yield0.19%
52W High₹1,008.43
52W Low₹327.25
Book Value₹78.40
EPS (TTM)₹14.29

Company Overview

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 18.2%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 24.0%.

Consistent Profit Growth

Net profit has compounded at 15.7% per year over the last five years.

Healthy Margins

Maintains a net profit margin of 26.2%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹947.32 Cr (-8.0% YoY); net profit ₹247.82 Cr.
  • Trailing 12 Months Year-on-year growth — revenue -8.0%, earnings -18.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 9.6%, profit CAGR 15.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:9.55%
1 Year:-8.03%

Compounded Profit Growth

5 Years:15.69%
1 Year:-18.80%

Stock Price Performance

1 Year:-33.88%
6 Months:+21.03%
3 Months:+45.27%
1 Month:+20.05%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 41% of range
₹327.25 ₹1,008.43
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • Golden Cross1d ago
  • RSI (14)68.49 · Neutral
Price Performance
1M+20.05%
3M+45.27%
6M+21.03%
1Y-33.88%
Valuation vs Sector

P/E of 42.37 is above the sector median of 39.70 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Healthy ROCE of 24.0%.
  • Excellent profit margin of 26.2%.
  • Profit CAGR of 15.7% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading 40.0% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
42.37
Industry PE
39.70
Forward P/E
31.79
PEG Ratio
-
Book Value
₹78.40
Price to Book
7.73
P/S
11.10
EV/EBITDA
34.62
Dividend Yield
0.19%

Growth (CAGR)

Revenue 5Y
9.55%
Profit 5Y
15.69%
Revenue (YoY)
-8.03%
Earnings (YoY)
-18.80%

Profitability & Returns

ROCE
23.96%
ROE
18.22%
ROA
15.10%
Profit Margin
26.16%
Op Margin
28.51%
Gross Margin
54.00%
EPS (Latest Qtr)
₹3.71
EPS (TTM)
₹14.29

Balance Sheet & Liquidity

Debt/Equity
3.10
Quick Ratio
3.38
Current Ratio
4.21
Debt
₹42.18 Cr
Total Assets
₹1,641.16 Cr
Current Assets
₹957.04 Cr
Working Capital
₹729.59 Cr

Ownership

Promoter Holding
73.14%
Chg in Prom Hold
-6.67%
FII / Inst Holding
1.73%
Chg in FII Hold
-0.25%

Financial Snapshot

Enterprise Value
₹10,501.60 Cr
Total Revenue (TTM)
₹947.32 Cr
EBITDA
₹362.75 Cr
Free Cash Flow
₹114.68 Cr
Operating Cash Flow
₹334.15 Cr
Shares Outstanding
₹17.35 Cr
Gross Margin
54.00%
Payout Ratio
8.40%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 BLUEJET Blue Jet Healthcare Limited NIFTY_SMALLNSEPHARMA 605.40 42.37 ₹10,501.60 Cr 0.19% 23.96% 18.22% 9.55% 15.69%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Revenue -318.38 Cr340.44 Cr354.76 Cr192.41 Cr234.67 Cr
Cost of Revenue -144.42 Cr153.47 Cr182.90 Cr92.85 Cr102.20 Cr
Gross Profit -173.96 Cr186.97 Cr171.86 Cr99.56 Cr132.47 Cr
Operating Expenses -54.69 Cr51.95 Cr56.56 Cr58.66 Cr67.65 Cr
Operating Income -119.27 Cr135.02 Cr115.30 Cr40.91 Cr64.81 Cr
EBITDA -137.25 Cr152.19 Cr129.25 Cr60.10 Cr94.19 Cr
Interest Expense -1.60 L3.40 L69.00 L33.90 L58.30 L
Pretax Income -132.49 Cr147.21 Cr122.86 Cr53.78 Cr87.15 Cr
Tax Provision -33.51 Cr37.12 Cr31.69 Cr13.61 Cr22.80 Cr
Net Income -98.98 Cr110.09 Cr91.17 Cr40.17 Cr64.34 Cr
Diluted EPS -5.716.355.262.323.71

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 538.00 Cr499.00 Cr-720.53 Cr710.32 Cr1,029.98 Cr947.32 Cr
Cost of Revenue ---344.29 Cr320.40 Cr461.22 Cr435.81 Cr
Gross Profit ---376.24 Cr389.91 Cr568.76 Cr511.51 Cr
Operating Expenses 324.00 Cr293.00 Cr-182.22 Cr187.38 Cr208.82 Cr241.41 Cr
Operating Income 196.00 Cr186.00 Cr-194.01 Cr202.53 Cr359.94 Cr270.10 Cr
EBITDA 214.00 Cr206.00 Cr-243.04 Cr248.34 Cr423.99 Cr362.75 Cr
Interest Expense 7.00 Cr5.00 Cr-1.36 Cr15.90 L9.80 L6.24 Cr
Pretax Income 194.00 Cr185.00 Cr-216.61 Cr220.09 Cr406.10 Cr332.51 Cr
Tax Provision 48.50 Cr48.10 Cr-56.58 Cr56.34 Cr100.90 Cr84.70 Cr
Net Income 145.00 Cr136.00 Cr-160.03 Cr163.75 Cr305.20 Cr247.82 Cr
Diluted EPS 24,141.671,396.49-9.239.4417.5914.29

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 375.00 Cr536.00 Cr-862.07 Cr1,058.85 Cr1,417.53 Cr1,641.16 Cr
Current Assets ---665.05 Cr705.64 Cr1,005.95 Cr957.04 Cr
Cash & Equivalents ---65.44 Cr40.95 Cr32.98 Cr60.86 Cr
Inventory ---125.66 Cr129.84 Cr263.92 Cr187.39 Cr
Receivables ---239.38 Cr176.93 Cr349.53 Cr339.05 Cr
Total Liabilities ---180.58 Cr213.62 Cr284.42 Cr281.25 Cr
Current Liabilities ---173.88 Cr205.96 Cr255.91 Cr227.46 Cr
Long Term Debt --000--
Total Debt 79.00 Cr53.00 Cr-3.44 Cr1.61 Cr19.99 Cr42.18 Cr
Total Equity 201.60 Cr340.00 Cr-681.49 Cr845.22 Cr1,133.11 Cr1,359.91 Cr
Shares Outstanding ---17.35 Cr17.35 Cr17.35 Cr17.35 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 123.00 Cr129.00 Cr-141.56 Cr241.26 Cr45.77 Cr334.15 Cr
Investing Cash Flow -45.00 Cr-51.00 Cr--147.25 Cr-263.75 Cr-35.18 Cr-275.58 Cr
Financing Cash Flow -72.00 Cr-28.00 Cr--4.24 Cr-1.99 Cr-18.56 Cr-30.69 Cr
Capital Expenditure -16.00 Cr-49.00 Cr--59.27 Cr-174.30 Cr-79.88 Cr-219.46 Cr
Free Cash Flow 107.00 Cr80.00 Cr-82.28 Cr66.96 Cr-34.12 Cr114.68 Cr
Net Change in Cash 5.00 Cr51.00 Cr--9.94 Cr-24.48 Cr-7.97 Cr27.88 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ---52.2%54.9%55.2%54.0%
Operating Margin % 36.4%37.3%-26.9%28.5%34.9%28.5%
Net Margin % 27.0%27.3%-22.2%23.1%29.6%26.2%
ROE % 71.9%40.0%-23.5%19.4%26.9%18.2%
ROCE % ---28.2%23.7%31.0%19.1%

Shareholding Pattern

Insiders
73.14%
Institutions
1.73%
Public Float
6.45%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BLUEJET

Google News Fri, 10 Jul 2026

Blue Jet Healthcare Raises ₹8,000 Million via Qualified Institutional Placement - The Globe and Mail

<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxQaUh1WmltVUxIN0Nic0pTMkM3al8tYVpPaTRINnN1Ylk2MHJ4YzJzSkxpbjJCdTVETWdKSWM0YWNjRmZRMWVFMnJfTk1OU3Z5Nm0yODB0M0VuRThFdXhZa21CZllacXlvME1HQThEd0FTdXZUc0VDOTVaYmFLN2J5WllqQ2g3dkV4d2xOcW…

Google News hu, 09 Jul 2026

BlueJet In Focus: D-Street's Little-Known Legend Nemish Shah Bets Strong On Pharma Firm - NDTV Profit

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQRUczck9Nd1hCMEJoWFZiTW5yNWxkajVQU3h3TGV0QnU2c1UwNmVXQ014SkQ1ZEpBQUZ1R1V4TzlnSXdTaHF3dGpsNlZOU1V6a0o4aE5NN3pnd0lyMXAzbWRodVhHZE5xU0F0a285bXNDaWFtSWt5dEhwV0hwMi16UWxwT1kydW5Kb0p3Zj…

Google News Fri, 10 Jul 2026

Blue Jet Healthcare raises ₹800 crore via QIP, two institutions get nearly 67% of shares - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxQU3lHN0xCUWI3d09tc000QWJjSExObjFWU2pwU1VhNlRPU1ctQXg5Vk1WWEZUb2dZcWNwRldnZ0xzdUo4eHZsY1U3VXJxSHppWnVmbEtoQnRqbVp6SGJIU1I5bEFTQ1V1RFIySUExVWFXdnBYYlBOSjBIcHg3eXBYODJOUjQtaUozMWpBRW…

Google News Mon, 25 May 2026

Blue Jet Healthcare up 10% as net profit rises 60% sequentially in Q4, firm announces Rs 1,000-cr fund raise - TradingView

<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxNSXJEd0F1Zmh5MjM4NXNpUmFsdXJxQWpmSS03YTFOMXFxVXpoLXdjZTZnSjY2R2N4ZVBGVm9sUzhEbDRYYkUyUEVIUUE4c3NBRVFxM19yTWU4dFkwNllzanY0dEZBNllLMWhlbWJJYjNqUlhMeTliVW9fSHQ3ejlJdDlyS3Y2bVNtZHRLbW…

Google News hu, 18 Jun 2026

Blue Jet Healthcare approves fund raising via equity - scanx.trade

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNbTlSREE1Ym1FN3JsVnpEUnI5ZWxhWVgzMFplTXBwZmlJcmZfUGJJZ09LOUZHVVdidUZJYkU3X25jdlBQODhvS09yT19kWmgwNFI5WERsaEpVUTNrNEdLaU5Fa3BLekRyblB3WFRraTVpRkFrUExhR2JYUDRKc2N3YVpDNUVzbU9BQ25GRW…

Google News Wed, 18 Feb 2026

Earnings Miss: Blue Jet Healthcare Limited Missed EPS By 35% And Analysts Are Revising Their Forecasts - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxPQ3drUlhzb3hpNTh1Sm9yQ0JzZ2htWE5UOElPVmU1VlRGYUpHZnJLS2JzOFJvRVlodjFSQmZwdktZd0tXZ1N2YVpLNkswV0xWTURFOXV6Zk8zR0poS0VzcVFGajhHUjhiWndXb1kxRW5FT3BxWmJ1LUtTQ1dBOVduWVB5VGk1dm85MnJvVk…

BLUEJET — Frequently Asked Questions

What is the current share price of Blue Jet Healthcare Limited (BLUEJET)?

As of 2026-07-16 05:21 IST, Blue Jet Healthcare Limited (BLUEJET) trades at ₹605.40 on NSE. Its 52-week range is ₹327.25 to ₹1,008.43.

What is the market capitalisation of BLUEJET?

Blue Jet Healthcare Limited (BLUEJET) has a market capitalisation of ₹10,501.60 Cr on NSE.

What is the P/E ratio of BLUEJET?

BLUEJET trades at a trailing price-to-earnings (P/E) ratio of 42.37. The industry average P/E is 39.70. Its price-to-book (P/B) ratio is 7.73.

Does BLUEJET pay a dividend?

Blue Jet Healthcare Limited (BLUEJET) currently offers a dividend yield of 0.19%.

What is the return on equity (ROE) of BLUEJET?

BLUEJET has a return on equity (ROE) of 18.22%. Its return on capital employed (ROCE) is 23.96%.

Is BLUEJET a good stock to buy?

This page provides a data-driven analysis of Blue Jet Healthcare Limited (BLUEJET), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space